The MESA IC device market will grow modestly through 2028, driven by the rising prevalence of CAD, expanding penetration of IC procedures, increasing health insurance coverage in some segments, and government initiatives to improve the accessibility and affordability of IC devices. Growth in this market will be further supported by physician training, as well as rising adoption of premium-priced next-generation IC products, such as DES, BRS, specialty balloon catheters, DCBs, IVUS catheters, and FFR guidewires. However, generally unfavorable reimbursement policies and the cost-sensitive nature of the countries covered, coupled with the impact of the COVID-19 pandemic, will limit market growth to some degree.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IC devices in the MESA region across a 10-year period.
Several emerging devices that are about to be launched in the US or European market will likely enter the MESA market in the coming years.
Which devices are anticipated to enter the MESA market over the forecast period?
How will the availability of these new devices impact the overall market?
The implementation of new medical device regulations in Turkey will result in more stringent regulatory requirements.
How are competitors expected to respond to the regulations and how will this affect small- and mid-sized emerging competitors in particular?
Will these regulations impact product launches and product improvements?
In several Middle Eastern countries, the PTCA Balloon catheter market will be significantly affected by device reuse.
In which countries is device reuse more prevalent? How will this trend affect unit sales and revenues?
How will this trend change going forward?
The MESA IC device market will be impacted by the COVID-19 pandemic in the early years of the forecast.
What guidance or recommendations have been issued for IC procedures in the face of infection containment and self isolation measures?
How will the pandemic impact clinical trials and product launches?
- Interventional Cardiology Devices - Market Insights - Middle East And South Africa
Author(s): Sangeetha Iyer, Pharm.D
Sangeetha Iyer is an analyst within the Cardiovascular Medtech Insights team at Decision Resource Group, specializing in structural heart closure and vascular access device markerts across the Asia Pacific region, as well as medical device pricing and regulations in China and Japan. Sangeetha has represnted India at the European Society of Cardiology confrerence in Greece(2016) and Sweden(2017), where her research poster was awarded the top prize. Sangeetha holds a Doctor of Pharmacy degree from the Manipal Academy of Higher Education. Follow Sangeetha on twitter: @Slyer_DRG